Main > A1. CORP. INDEX. T-Tm > Takeda Pharma./P C2
This data is not available for free
Takeda Pharma./P C2's subsections
2002. 12.02.2002. Diab.
2003. 05.05.2003. Urology
2003. 05.26.2003. AIDS
2003. 08.01.2003. Alzheimers
2003. 08.04.2003. Boost US Operatio
2004. 07.28.2004. Lexicon Gene..
2008. 01.25.2008. Onco.
2008. 03.19.2008. TAP Conclusion
2008. 06.02.2008. RNAi Technology
2008. 12.08.2008. Drug Discov Lab.
2009. 04.06.2009. Drug Dev
2009. 04.06.2009. Marketing; Comm.
2009. 04.06.2009. NA Operations
2009. 04.06.2009. Pres.
2009. 12.15.2009. Seattle Genetics
2011. 02.26.2011. Cardio.
2011. 08.22.2011. Influenza Vaccine
2011. 12.20.2011. Cardio.
2012. 01.18.2012. Cardio.
2012. 01.18.2012. Strategic Measure
2012. 01.23.2012. Onco.>Bortezomib
2012. 02.21.2012. GI>Ulcerative Col
2012. 03.06.2012. Onco.>PTCL
2012. 04.11.2012. Corp. Acq.
2012. 05.25.2012. Acq. BR Multilab
2012. 06.18.2012. Pfizer JP Dist.
2012. 06.26.2012. Appointments
2012. 09.05.2012. GI>SBS
2012. 09.12.2012. RU Mfg. Facility
2012. 10.03. Advinus Therap.
2012. 11.06. Envoy Therapeutics Acq
2012. 12.25. Amylin/Obesity
2013. 03.18. Scripps Res.
2013. 06.24. Sr. Leadership &
2013. 07.31. Diab.>Alogliptin
2013. 08.22. Subsidiary in Peru
2013. 08.27. Neuro.>AD
2013. 11.30. COO
2013. 12.20. GI>Crohns Dis. & UC>N
2013. 12.27. Diab.>Fasiglifam
2014. 03.20. New Sr. Leadership
2014. 03.31. Influenza Vaccine H5N1
2014. 05.20. GI>Crohns Dis. & UC>V
2014. 06.19. Onco.>Prostate C.
2014. 12.01. AL Amyloidosis
2014. 12.08. Takeda Oncology
2015. 02.26. Gastro.>Acid Related
2015. 03.24. ImmunoGen
2015. 04.01. Osaka Gas
2015. 07.27. Visceral Leishmaniasis
2015. 11.20. Onco.>MM
2016. 01.27. GI>GERD
2016. 02.10. AD>Zinfandel./P
2016. 03.14. Outpost Medicine
2016. 05.03. Depression>MDD
2016. 06.08. Ultragenyx Pharma
2016. 07.04. GI>Gastroparesis>Altos
2016. 07.05. GI>Crohn s>TiGenix
2016. 08.08. Onco.>MM
2016. 09.02. Zika Vaccine
2016. 09.12. PRA Health Sciences
2016. 12.02. CereVance
2017. 01.18. Ovid Therapeutics
2017. 01.30. Onco.>RCC>Exelixis
2017. 02.28. Bushu Pharma. Ltd.
2017. 03.13. Scohia Pharma
2017. 04.05. Finch Therapeutics
2017. 04.11. NuBiyota
2017. 04.27. Harrington Discovery
2017. 04.29. Onco.>Lung C.
2017. 05.09. GammaDelta Therapeutic
2017. 07.10. Contract R&D Firm
2017. 07.21. Schrodinger
2017. 07.27. Onco.>Ovarian C.
2017. 11.07. Portal Instruments
2018. 01.04. Denali Therapeutics
2018. 01.05. Acq. TiGenix NV.!
2018. 02.08. Cardio. Fujifilm
2018. 02.20. Wave Life Sciences
2019. 01.03. Onco.>Immuno-Onco
2019. 05.17. Gastro.>SBS
2020. 02.26. Celiac DIS. 2 USA PATs
2020. 03.04. COVID-19
2020. 03.23. Gastro.>UC & CD
2020. 05.14. Onco.>sALCL>EU>OK
2020. 05.22. Onco.>LC>USA>OK
2020. 10.08. AATLD>ARO-AAT>Arrowhea
2020. 12.08. Hemato.>HAE>CN>OK
2021. 03.03. Neuro.>Soticlestat>
2021. 03.09. Acq. Maverick Therap.
2021. 07.29. Norovirus Vaccine
2021. 09.15. Onco.>NSCLC
2021. 10.27. Acq. GammaDelta Therap
2021. 11.24. PostTransplant CMV
2022. 03.28. Hema.>HAE>JP>OK
2022. 10.20. Celiac DIS.
2022. 11.11. EU Approval
2022. 12.08. Dengue Vacc>EU>OK
2022. 12.13. Nimbus Therapeutics
2023. 01.11. Onco.>NSCLC>CN>OK
2023. 04.11. Immuno>PI>Children>
2023. 09.25. JP Approval
2023. 10.18. Onco.>HL>EU>OK
2023. 11.08. Onco.>mCRC>USA>OK
2023. 11.09. Hemato.>cTTP>USA>OK
2024. 01.29. Neuro.>CIDP>EU>OK
2024. 01.29. Neuro.>CIDP>USA>OK
2024. 02.12. Gastro.>EoE>USA>OK
2024. 03.19. Onco.>Ph+ ALL>USA>OK
2024. 03.26. Hemato.>cTTP>JP>OK
Patents
Syrrx/P
Takeda Cambridge/P C2
Takeda Chemical/P
Takeda Oncology. C2
Takeda Pharma. Intl. GmbH. C2
Takeda Pharma. USA Inc. C2
Takeda Research Investment C2
Takeda San Diego/P C2
Takeda Ventures. C2
Tap/P (GastroEntero.)
Web-Site
Z - OK
Takeda Pharma./P C2's products
This section has no products